Bausch Health Co. Inc. (BHC) Reports In-Line Q2 Revenue, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Bausch Health Companies Inc. Announces Second-Quarter 2021 Results
August 3, 2021 6:59 AM EDTLAVAL, Quebec, Aug. 3, 2021 /PRNewswire/ --
Second-Quarter 2021 Financial Results Revenues of $2.100 Billion GAAP Net Loss of $595 Million Adjusted EBITDA (non-GAAP)1Â of $826 Million GAAP Cash Generated from Operations of $395 Million Thomas J. Appio Appointed CEO of Bausch Pharma2Â Bausch Health Announced Plans to Pursue an Initial Public Offering for Solta Medical3 Revised 2021 Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance Ranges, Primarily to Reflect Amoun Pharmaceutical DivestitureBausch Health Companies Inc.... More
